Skip to main content

Euclidean Capital LLC

SEC CIK
0001825034
Latest filing
Aug 14, 2026

Holdings in Q2 2021

Holdings as of Jun 30, 2021, filed Nov 15, 2021. Long positions only; changes compare share counts with Q1 2021.

Institution overview
Positions
14
+1 vs. Q1 2021
Portfolio value
$308.1M
+$9.21M (+3.1%) vs. Q1 2021
Filed
Nov 15, 2021
AmendedSEC
Holdings of Euclidean Capital LLC in Q2 2021
SecurityClassSharesValue% of portfolioShare changeActionHistory
PMVPPMV Pharmaceuticals, Inc.COM3,908,677$133.5M43.3%−270,739−6.5%ReducedHistory
NGMNGM Biopharmaceuticals IncCOM1,493,349$29.4M9.6%00.0%UnchangedHistory
DNLIDenali Therapeutics Inc.COM323,749$25.4M8.2%00.0%UnchangedHistory
RAPTRAPT Therapeutics, Inc.COM735,801$23.4M7.6%00.0%UnchangedHistory
ALECAlector, Inc.COM980,894$20.4M6.6%00.0%UnchangedHistory
CNSTConstellation Pharmaceuticals IncCOM554,325$18.7M6.1%00.0%UnchangedHistory
ORICOric Pharmaceuticals, Inc.COM996,734$17.6M5.7%00.0%UnchangedHistory
FHTXFoghorn Therapeutics Inc.COM1,261,261$13.5M4.4%00.0%UnchangedHistory
SNOWSnowflake Inc.Stock47,136$11.4M3.7%+47,136NewHistory
FFBCFirst Financial BancorpCOM173,576$4.10M1.3%00.0%UnchangedHistory
NRIXNurix Therapeutics, Inc.COM154,426$4.10M1.3%+154,426NewHistory
BEAMBeam Therapeutics Inc.COM31,131$4.01M1.3%00.0%UnchangedHistory
PDDPDD Holdings Inc.SPONSORED ADS9,806$1.25M0.4%+1,632+20.0%AddedHistory
VIRVir Biotechnology, Inc.COM25,866$1.22M0.4%+20.0%AddedHistory

Sold out since Q1 2021 (1)

Positions held at the end of Q1 2021 that are gone from this filing.

Positions of Euclidean Capital LLC sold out since Q1 2021
SecurityClassShares in Q1 2021Value in Q1 2021% of portfolio in Q1 2021History
RUBYRubius Therapeutics, Inc.COM12,791$339.0K0.1%History